Kartik Cherabuddi, MD, FACP, FIDSA, FIDSA - Research

Research at a glance

Top areas of exploration

Anti-Bacterial Agents , 11 publications
COVID-19 , 5 publications
Cross Infection , 4 publications
Cefepime , 4 publications

Research activity

67 publications

1,136 citations

Why is this important?

Focus

Multidrug resistant infections

Antimicrobial alternatives to antibiotics

Therapeutic drug monitoring and personalized medicine

Emerging global infections

NTM infections in Transplant patients

Infectious disease fellow, Internal medicine resident and Medical student education

Active clinical trials

RECOVER-AD

This study is a platform protocol designed to be flexible so that it is suitable for a wide range of settings within health care systems and in community settings where it can be integrated into COVID-19 programs and subsequent treatment plans. This鈥�

Investigators: Vidhu Kariyawasam, Kartik Cherabuddi
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

My publications

67 publications

2025

Development and implementation of learning collaboratives for infection prevention and control education in long-term care facilities.

American journal of infection control

鈥�

2025

Infection prevention and control in long-term care facilities in Florida: A needs assessment survey.

American journal of infection control

鈥�

2024

Brincidofovir for disease progression due to suspected tecovirimat resistance in association with advanced HIV.

International journal of STD & AIDS

鈥�

2024

Implementing the Infectious Diseases Society of America Antimicrobial Stewardship Core Curriculum: Survey Results and Real-World Strategies to Guide Fellowship Programs.

Open forum infectious diseases

鈥�

2023

A new antifungal drug for candidaemia

The Lancet Infectious Diseases

BOB体育